CUSIP 55083R104COMLYELQ4 2025
18 filings · latest Aug 19, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Decheng Capital LLC | 692.0K | $21.30M |
| 4 | Feb 14, 2025 | Arch Venture Fund Ix, L.P. | 13G/A | 13.1% | 36.60M | SEC |
| 5 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 4.5% | 13.27M | SEC |
| 6 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 3.9% | 10.07M | SEC |
| 7 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 3.9% | 10.07M | SEC |
| 8 | Oct 31, 2024 | Foresite Capital Fund IV, L.P. | 13G | 3.2% | 8.32M | SEC |
| 9 | Feb 14, 2024 | Arch Venture Fund Ix, L.P. | 13G/A | 14.5% | 36.41M | SEC |
| 10 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 5.4% | 13.60M | SEC |
See the full Schedule 13D/13G history for Lyell Immunopharma Inc.
Unlock full history